1-[(3-methoxyphenyl)methyl]-N-methyl-2-oxo-3-(4-pyrazolidin-4-ylphenyl)-1,3,8-triazaspiro[4.5]decane-8-carboxamide

C26H34N6O3 — CID 155922035

IUPAC1-[(3-methoxyphenyl)methyl]-N-methyl-2-oxo-3-(4-pyrazolidin-4-ylphenyl)-1,3,8-triazaspiro[4.5]decane-8-carboxamide
SMILESCNC(=O)N1CCC2(CC1)CN(c1ccc(C3CNNC3)cc1)C(=O)N2Cc1cccc(OC)c1
InChIInChI=1S/C26H34N6O3/c1-27-24(33)30-12-10-26(11-13-30)18-31(22-8-6-20(7-9-22)21-15-28-29-16-21)25(34)32(26)17-19-4-3-5-23(14-19)35-2/h3-9,14,21,28-29H,10-13,15-18H2,1-2H3,(H,27,33)
InChIKeyNHCFUFMMWMTGGK-UHFFFAOYSA-N
MW478.60 g/mol
LogP2.50
Rot. Bonds5

About 1-[(3-methoxyphenyl)methyl]-N-methyl-2-oxo-3-(4-pyrazolidin-4-ylphenyl)-1,3,8-triazaspiro[4.5]decane-8-carboxamide

1-[(3-methoxyphenyl)methyl]-N-methyl-2-oxo-3-(4-pyrazolidin-4-ylphenyl)-1,3,8-triazaspiro[4.5]decane-8-carboxamide (PubChem CID 155922035) has the molecular formula C26H34N6O3 and a molecular weight of 478.60 g/mol. Its IUPAC name is 1-[(3-methoxyphenyl)methyl]-N-methyl-2-oxo-3-(4-pyrazolidin-4-ylphenyl)-1,3,8-triazaspiro[4.5]decane-8-carboxamide.

Molecular Properties

Compound Name1-[(3-methoxyphenyl)methyl]-N-methyl-2-oxo-3-(4-pyrazolidin-4-ylphenyl)-1,3,8-triazaspiro[4.5]decane-8-carboxamide
PubChem CID155922035
Molecular FormulaC26H34N6O3
Molecular Weight478.60 g/mol
Exact Mass478.27
IUPAC Name1-[(3-methoxyphenyl)methyl]-N-methyl-2-oxo-3-(4-pyrazolidin-4-ylphenyl)-1,3,8-triazaspiro[4.5]decane-8-carboxamide
SMILESCNC(=O)N1CCC2(CC1)CN(c1ccc(C3CNNC3)cc1)C(=O)N2Cc1cccc(OC)c1
InChIInChI=1S/C26H34N6O3/c1-27-24(33)30-12-10-26(11-13-30)18-31(22-8-6-20(7-9-22)21-15-28-29-16-21)25(34)32(26)17-19-4-3-5-23(14-19)35-2/h3-9,14,21,28-29H,10-13,15-18H2,1-2H3,(H,27,33)
InChIKeyNHCFUFMMWMTGGK-UHFFFAOYSA-N
XLogP2.50
TPSA89.18 Ų
H-Bond Donors3
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms35
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500478.60
LogP ≤ 52.50
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 105

Analyze 1-[(3-methoxyphenyl)methyl]-N-methyl-2-oxo-3-(4-pyrazolidin-4-ylphenyl)-1,3,8-triazaspiro[4.5]decane-8-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[(3-methoxyphenyl)methyl]-N-methyl-2-oxo-3-(4-pyrazolidin-4-ylphenyl)-1,3,8-triazaspiro[4.5]decane-8-carboxamide?
The IUPAC name of 1-[(3-methoxyphenyl)methyl]-N-methyl-2-oxo-3-(4-pyrazolidin-4-ylphenyl)-1,3,8-triazaspiro[4.5]decane-8-carboxamide (CID 155922035) is 1-[(3-methoxyphenyl)methyl]-N-methyl-2-oxo-3-(4-pyrazolidin-4-ylphenyl)-1,3,8-triazaspiro[4.5]decane-8-carboxamide.
What is the SMILES notation for 1-[(3-methoxyphenyl)methyl]-N-methyl-2-oxo-3-(4-pyrazolidin-4-ylphenyl)-1,3,8-triazaspiro[4.5]decane-8-carboxamide?
The canonical SMILES for 1-[(3-methoxyphenyl)methyl]-N-methyl-2-oxo-3-(4-pyrazolidin-4-ylphenyl)-1,3,8-triazaspiro[4.5]decane-8-carboxamide is CNC(=O)N1CCC2(CC1)CN(c1ccc(C3CNNC3)cc1)C(=O)N2Cc1cccc(OC)c1.
What is the InChIKey of 1-[(3-methoxyphenyl)methyl]-N-methyl-2-oxo-3-(4-pyrazolidin-4-ylphenyl)-1,3,8-triazaspiro[4.5]decane-8-carboxamide?
The InChIKey is NHCFUFMMWMTGGK-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H34N6O3/c1-27-24(33)30-12-10-26(11-13-30)18-31(22-8-6-20(7-9-22)21-15-28-29-16-21)25(34)32(26)17-19-4-3-5-23(14-19)35-2/h3-9,14,21,28-29H,10-13,15-18H2,1-2H3,(H,27,33).
What are the key properties of 1-[(3-methoxyphenyl)methyl]-N-methyl-2-oxo-3-(4-pyrazolidin-4-ylphenyl)-1,3,8-triazaspiro[4.5]decane-8-carboxamide?
1-[(3-methoxyphenyl)methyl]-N-methyl-2-oxo-3-(4-pyrazolidin-4-ylphenyl)-1,3,8-triazaspiro[4.5]decane-8-carboxamide has a molecular weight of 478.60 g/mol, XLogP of 2.50, 5 rotatable bonds, 3 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[(3-methoxyphenyl)methyl]-N-methyl-2-oxo-3-(4-pyrazolidin-4-ylphenyl)-1,3,8-triazaspiro[4.5]decane-8-carboxamide is sourced from PubChem (CID 155922035), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).